A comparison of the clinical courses of type 2 diabetic patients whose basal insulin preparation was replaced from insulin glargine 100 units/mL to insulin glargine biosimilar or 300 units/mL: a propensity score-matched observation study

Hiroyuki ItoDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan; Correspondence[email protected]

Emiko TsugamiDepartment of Pharmacy, Edogawa Hospital, Tokyo, Japan

Shigenori AndoDepartment of Pharmacy, Edogawa Hospital, Tokyo, Japan

Rie ArakiDepartment of Pharmacy, Edogawa Hospital, Tokyo, Japan

Suzuko MatsumotoDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan;

Kosuke UemuraDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan;

Shinya NishioDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan;

Shinichi AntokuDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan;

Tomoko YamasakiDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan;

Toshiko MoriDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan;

Michiko ToganeDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan;

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.